Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...
MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...